|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:activeIngredient
|
gptkb:tozinameran
|
|
gptkbp:administeredBy
|
over 100 countries
|
|
gptkbp:age
|
6 months and older
|
|
gptkbp:approvedBy
|
gptkb:European_Union
gptkb:United_States
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
2020
|
|
gptkbp:ATCCode
|
gptkb:J07BX03
|
|
gptkbp:boosterDoseRecommended
|
yes
|
|
gptkbp:boosterRecommended
|
yes
|
|
gptkbp:brand
|
gptkb:BNT162b2
|
|
gptkbp:CDCCode
|
91307
91300
91305
91306
91308
91309
91312
91313
91314
91315
|
|
gptkbp:CDCRecommended
|
yes
|
|
gptkbp:contains
|
gptkb:plastic
gptkb:disodium_hydrogen_phosphate
sodium chloride
potassium chloride
sucrose
lipid nanoparticles
potassium dihydrogen phosphate
water for injection
|
|
gptkbp:developedBy
|
gptkb:Pfizer
gptkb:BioNTech
|
|
gptkbp:EMARecommended
|
yes
|
|
gptkbp:emergencyServices
|
yes
|
|
gptkbp:form
|
suspension for injection
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Comirnaty
|
|
gptkbp:indication
|
prevention of COVID-19
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
gptkb:BioNTech
|
|
gptkbp:marketedAs
|
gptkb:Pfizer
gptkb:BioNTech
|
|
gptkbp:numberOfDoses
|
2 primary doses
|
|
gptkbp:pregnancyCategory
|
consult healthcare provider
no known risk in pregnancy
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
fever
fatigue
headache
joint pain
muscle pain
pericarditis
anaphylaxis
chills
myocarditis
pain at injection site
|
|
gptkbp:storage
|
-80°C to -60°C
|
|
gptkbp:type
|
vaccine
|
|
gptkbp:WHOPrequalified
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Pfizer
|
|
gptkbp:bfsLayer
|
4
|